Skip to main content

Advertisement

SpringerLink
Log in

Emergence of Secondary Resistance to Imatinib in Recurrent Gastric GIST

  • Letter to the Editor
  • Published:
Journal of Gastrointestinal Surgery Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Dudeja V, Armstrong LH, Gupta P, Ansel H, Askari S, Al-Refaie WB. Emergence of imatinib resistance associated with downregulation of c-kit expression in recurrent gastrointestinal stromal tumor (GIST): optimal timing of resection. J Gastrointest Surg;14(3):557–61.

  2. Fletcher CD, Berman JJ, Corless C, Gorstein F, Lasota J, Longley BJ, et al. Diagnosis of gastrointestinal stromal tumors: a consensus approach. Hum Pathol 2002;33(5):459–65.

    Article  PubMed  Google Scholar 

  3. Miettinen M, Lasota J. Gastrointestinal stromal tumors: review on morphology, molecular pathology, prognosis, and differential diagnosis. Arch Pathol Lab Med 2006;130(10):1466–78.

    CAS  PubMed  Google Scholar 

  4. Miettinen M, Sobin LH, Lasota J. Gastrointestinal stromal tumors of the stomach: a clinicopathologic, immunohistochemical, and molecular genetic study of 1765 cases with long-term follow-up. Am J Surg Pathol 2005;29(1):52–68.

    Article  PubMed  Google Scholar 

  5. Miettinen M, Makhlouf H, Sobin LH, Lasota J. Gastrointestinal stromal tumors of the jejunum and ileum: a clinicopathologic, immunohistochemical, and molecular genetic study of 906 cases before imatinib with long-term follow-up. Am J Surg Pathol 2006;30(4):477–89.

    Article  PubMed  Google Scholar 

  6. Joensuu H. Sunitinib for imatinib-resistant GIST. Lancet 2006;368(9544):1303–4.

    Article  PubMed  Google Scholar 

  7. Heinrich MC, Maki RG, Corless CL, Antonescu CR, Harlow A, Griffith D, et al. Primary and secondary kinase genotypes correlate with the biological and clinical activity of sunitinib in imatinib-resistant gastrointestinal stromal tumor. J Clin Oncol 2008;26(33):5352–9.

    Article  CAS  PubMed  Google Scholar 

  8. George S, Blay JY, Casali PG, Le Cesne A, Stephenson P, Deprimo SE, et al. Clinical evaluation of continuous daily dosing of sunitinib malate in patients with advanced gastrointestinal stromal tumour after imatinib failure. Eur J Cancer 2009;45(11):1959–68.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Laparoscopic Upper GI Surgery, Colchester University Hospital, Colchester, UK

    Naga Venkatesh Gupta Jayanthi

Authors
  1. Naga Venkatesh Gupta Jayanthi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Naga Venkatesh Gupta Jayanthi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jayanthi, N.V.G. Emergence of Secondary Resistance to Imatinib in Recurrent Gastric GIST. J Gastrointest Surg 14, 2018–2019 (2010). https://doi.org/10.1007/s11605-010-1302-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11605-010-1302-z

Keywords

Search

Navigation